Pharmacological Consequence of the A118G μ Opioid Receptor Polymorphism on Morphine- and Fentanyl-mediated Modulation of Ca2+Channels in Humanized Mouse Sensory Neurons
Open Access
- 1 November 2011
- journal article
- pain medicine
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesiology
- Vol. 115 (5), 1054-1062
- https://doi.org/10.1097/aln.0b013e318231fc11
Abstract
Background The most common functional single nucleotide polymorphism of the human OPRM1 gene, A118G, has been shown to be associated with interindividual differences in opioid analgesic requirements, particularly with morphine, in patients with acute postoperative pain. The purpose of this study was to examine whether this polymorphism would modulate the morphine and fentanyl pharmacological profile of sensory neurons isolated from a humanized mouse model homozygous for either the 118A or 118G allele. Methods The coupling of wild-type and mutant μ opioid receptors to voltage-gated Ca channels after exposure to either ligand was examined by employing the whole cell variant of the patch-clamp technique in acutely dissociated trigeminal ganglion neurons. Morphine-mediated antinociception was measured in mice carrying either the 118AA or 118GG allele. Results The biophysical parameters (cell size, current density, and peak current amplitude potential) measured from both groups of sensory neurons were not significantly different. In 118GG neurons, morphine was approximately fivefold less potent and 26% less efficacious than that observed in 118AA neurons. On the other hand, the potency and efficacy of fentanyl were similar for both groups of neurons. Morphine-mediated analgesia in 118GG mice was significantly reduced compared with the 118AA mice. Conclusions This study provides evidence to suggest that the diminished clinical effect observed with morphine in 118G carriers results from an alteration of the receptor's pharmacology in sensory neurons. In addition, the impaired analgesic response with morphine may explain why carriers of this receptor variant have an increased susceptibility to become addicted to opioids.Keywords
This publication has 36 references indexed in Scilit:
- Association of human μ‐opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patientsAnaesthesia, 2009
- Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgeryPain, 2009
- Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatmentPain, 2009
- Mouse model ofOPRM1(A118G) polymorphism has sex-specific effects on drug-mediated behaviorProceedings of the National Academy of Sciences of the United States of America, 2009
- Role of voltage-gated calcium channels in ascending pain pathwaysBrain Research Reviews, 2009
- A Common Human μ-Opioid Receptor Genetic Variant Diminishes the Receptor Signaling Efficacy in Brain Regions Processing the Sensory Information of PainOnline Journal of Public Health Informatics, 2009
- Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women ☆Pain, 2008
- A118G Single Nucleotide Polymorphism of Human μ-Opioid Receptor Gene Influences Pain Perception and Patient-controlled Intravenous Morphine Consumption after Intrathecal Morphine for Postcesarean AnalgesiaAnesthesiology, 2008
- GENETIC STUDY: Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependenceAddiction Biology, 2008
- The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptorJournal of Neurochemistry, 2007